APA

Kozłowski M., Laudański W., Mroczko B., Szmitkowski M., Milewski R. & Łapuć G. (20140626). Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients. : Advances in medical sciences.

Chicago

Kozłowski M, Laudański W, Mroczko B, Szmitkowski M, Milewski R and Łapuć G. 20140626. Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients. : Advances in medical sciences.

Harvard

Kozłowski M., Laudański W., Mroczko B., Szmitkowski M., Milewski R. and Łapuć G. (20140626). Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients. : Advances in medical sciences.

MLA

Kozłowski M, Laudański W, Mroczko B, Szmitkowski M, Milewski R and Łapuć G. Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients. : Advances in medical sciences. 20140626.